Oyazato Yoshinobu, Iijima Kazumoto, Emi Mitsuru, Sekine Takashi, Kamei Koichi, Takanashi Junichi, Nakao Hideto, Namai Yoshiyuki, Nozu Kandai, Matsuo Masafumi
Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Kobe J Med Sci. 2011 Jun 9;57(1):E1-10.
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations in either of two genes, TSC1 and TSC2. Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in either PKD1 or PKD2. TSC2 lies immediately adjacent to PKD1 and large heterozygous deletions can result in the TSC2/PKD1 contiguous gene syndrome (PKDTS). PKDTS has been identified in patients with TSC and early-onset severe ADPKD. However, genetic diagnosis with conventional methods proved to be difficult because its genetic aberrations are large monoallelic mutations.
In the study presented here, we used both multiplex ligation-dependent probe amplification (MLPA) and array comparative genomic hybridization (array-CGH) for four PKDTS patients.
We were able to detect large heterozygous deletions including TSC2 and PKD1 by both of MLPA and array-CGH in all four patients. And in two patients, array-CGH identified relatively large genomic aberrations (RAB26, NTHL1, etc.), that extended outside of TSC2 or PKD1.
The identical results obtained with these two completely different methods show that both constitute highly reliable strategies. Only a few studies have determined the breakpoints of large deletions in this disease and ours is the first to have identified the breakpoints by using array-CGH. We suggest that these methods are not only useful for the diagnosis of PKDTS but also for elucidation of its molecular mechanism.
结节性硬化症(TSC)是一种常染色体显性疾病,由TSC1和TSC2这两个基因中的任意一个发生突变引起。常染色体显性多囊肾病(ADPKD)由PKD1或PKD2发生突变引起。TSC2紧邻PKD1,大的杂合性缺失可导致TSC2/PKD1相邻基因综合征(PKDTS)。PKDTS已在患有TSC和早发性严重ADPKD的患者中得到确认。然而,由于其基因畸变是大的单等位基因突变,用传统方法进行基因诊断很困难。
在本文介绍的研究中,我们对4例PKDTS患者同时使用了多重连接依赖探针扩增技术(MLPA)和阵列比较基因组杂交技术(array-CGH)。
我们通过MLPA和array-CGH在所有4例患者中均检测到包括TSC2和PKD1的大的杂合性缺失。在2例患者中,array-CGH识别出相对较大的基因组畸变(RAB26、NTHL1等),这些畸变延伸至TSC2或PKD1之外。
这两种完全不同的方法得到相同结果,表明二者均是高度可靠的策略。仅有少数研究确定了该疾病中大缺失的断点,而我们的研究是首次通过使用array-CGH确定断点。我们认为这些方法不仅对PKDTS的诊断有用,而且对阐明其分子机制也有用。